Recent Updates
Recently added Catalysts
RCEL Negative Sentiment Score: 20/100

AVITA Medical, Inc. (RCEL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Key Takeaway: AVITA Medical, Inc. (RCEL) is facing a securities fraud investigation as shareholders who experienced financial losses seek recourse. An investigation by the Law Offices of Howard G. Smith highlights potential violations of federal securities laws due to a significant backlog in unpaid provider claims affecting the company's RECELL procedures. This backlog arose from inadequate pricing and claim adjudication delays by contractors from the Centers for Medicare & Medicaid Services. Consequently, after announcing these issues, Avita's stock saw a dramatic fall of 21%.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investors suffered losses due to a significant backlog of unpaid claims.
  • Avita's stock price dropped 21% following the release of poor financial results.
  • Uncertainty regarding payment expectations has reduced utilization of the RECELL product.

Full Press Release Details

BENSALEM, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AVITA MEDICAL, INC. (RCEL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
On August 7, 2025, Avita released its second quarter 2025 financial results, revealing “a six-month backlog in unpaid provider claims for Recell procedures impacted first-half demand.”
The Company explained that contractors assigned by the Centers for Medicare & Medicaid Services to determine pricing of the Company’s wound care product, Recell, “neither assigned a price or assigned an inadequate price and failed to adjudicate claims in a timely manner.”
As a result, “claims accumulated from January through June, creating a significant backlog of unpaid claims and inadequately paid claims to providers for RECELL procedures. This lack of resolution created uncertainty among providers regarding payment expectations and timelines, which led to a reduction in RECELL utilization during the first half of the year.”
On this news, Avita’s stock price fell $1.13, or 21%, to close at $4.25 per share on August 8, 2025, thereby injuring investors.
Contact Us To Participate or Learn More:
If you purchased Avita securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Visit our website at: www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Law Offices of Howard G. Smith
Howard G. Smith, Esquire

Tags

Frequently Asked Questions

What is the issue with Avita Medical, Inc.?

Avita Medical is under investigation for potential federal securities law violations.

How can I contact the Law Offices of Howard G. Smith?

You can reach them by email at howardsmith@howardsmithlaw.com or by phone at (215) 638-4847.

What caused Avita's stock price to drop?

The stock fell due to a backlog of unpaid claims from January to June 2025.

What happened during Avita's second quarter 2025 results?

They reported a backlog in unpaid provider claims affecting Recell's demand.

What should I do if I lost money in Avita investments?

Consider contacting the Law Offices of Howard G. Smith to discuss potential claims.

Last updated: Sep 30, 2025